- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00839462
Efficacy of Dexpanthenol in Thermic Erythema
October 18, 2013 updated by: Bayer
Evaluation of the Effect of Bepanthen Burn Relief Foam Spray New Formula on a Thermic Erythema. Equivalence Trial. Intra-individual Design.
The study focuses to prove the equivalent efficacy of two different Dexpanthenol formulations.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
55
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Villeurbanne, France, 69503
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy subjects
- Phototype: I to IV according to Fitzpatrick scale
Exclusion Criteria:
- Pregnant or nursing women
- Subjects registered as being in exclusion period in the French Health Minister file of subjects
- Subjects with known allergy to cosmetics, skin care products, or topical drugs, a sensitivity related to any component of any formulations being tested
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Arm 1
|
2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter
|
ACTIVE_COMPARATOR: Arm 2
|
2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Global sum of scores for evaluating the cooling/soothing effect evaluated after first and second application
Time Frame: 2 min, 5 min, 10 min, 15 min
|
2 min, 5 min, 10 min, 15 min
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Skin temperature
Time Frame: 2 min, 5 min, 10 min
|
2 min, 5 min, 10 min
|
Evaluation of the cooling/soothing effect (scores) after first and second application
Time Frame: 2 min, 5min, 10 min, 15 min
|
2 min, 5min, 10 min, 15 min
|
Evaluation of the foam covering properties after first application
Time Frame: 2 min, 5 min, 10 min, 15 min
|
2 min, 5 min, 10 min, 15 min
|
Incidence of adverse events
Time Frame: FPFV - LPLV
|
FPFV - LPLV
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2007
Primary Completion (ACTUAL)
September 1, 2007
Study Completion (ACTUAL)
September 1, 2007
Study Registration Dates
First Submitted
February 6, 2009
First Submitted That Met QC Criteria
February 6, 2009
First Posted (ESTIMATE)
February 9, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
October 21, 2013
Last Update Submitted That Met QC Criteria
October 18, 2013
Last Verified
October 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12039
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Erythema
-
Tufts Medical CenterRecruiting
-
VIST - Faculty of Applied SciencesRecruitingMinimal Erythema DoseSlovenia
-
University of British ColumbiaUnknownSurgical Scar ErythemaCanada
-
VIST - Faculty of Applied SciencesEuropean Regional Development Fund; Slovenian Research Agency; Valens Int. d.o... and other collaboratorsCompletedDermis Density | Minimal Erythema Dose | Skin ViscoelasticitySlovenia
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingErythema Multiforme
-
Robert MichelettiRecruiting
-
Skin Laser & Surgery SpecialistsGalderma R&DTerminatedErythema and Flushing Associated With Rosacea
-
National Institute of Allergy and Infectious Diseases...Completed
-
University Medical Centre LjubljanaUnknown
-
Postgraduate Institute of Medical Education and...CompletedErythema Nodosum LeprosumIndia
Clinical Trials on Dexpanthenol foam spray, new formulation
-
GenfitNaturalpha; SGS Aster S.A.S.CompletedCardiovascular Diseases | Metabolic Diseases | Diabetes Mellitus, Type 2 | Type 2 Diabetes | Dyslipidemia | ObeseFrance
-
GlaxoSmithKlineCompletedSubstance DependenceUnited Kingdom
-
The Netherlands Cancer InstituteCompleted
-
LEO PharmaBayerCompleted
-
TakedaCompleted
-
LEO PharmaBayerCompleted
-
GlaxoSmithKlineCompleted
-
Boehringer IngelheimTerminated